Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.970
+0.360 (7.81%)
Jan 22, 2026, 3:02 PM EST - Market open
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.59 billion as of January 22, 2026. Its market cap has decreased by -15.92% in one year.
Market Cap
2.59B
Enterprise Value
1.96B
1-Year Change
-15.92%
Ranking
Category
Stock Price
$4.97
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.59B, a decrease of -49.04%. That is a compound annual growth rate of -13.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.40B | 12.71% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 2.64B |
| Wave Life Sciences | 2.55B |
| Travere Therapeutics | 2.53B |
| Mineralys Therapeutics | 2.48B |
| Ocular Therapeutix | 2.43B |
| Telix Pharmaceuticals | 2.43B |
| Ascentage Pharma Group International | 2.36B |
| Soleno Therapeutics | 2.34B |